TuHURA Biosciences, Inc.(HURA)

Biotechnology · Tampa, FL

$1.92+0.05 (+2.61%)

Delayed quote: Oct 6, 2026, 9:32 AM EDT

PE Ratio: N/A

Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

The P/E ratio is N/A as of 2026-10-06T13:37:26.285Z.

Stored calculation inputs

Calculation as of: 2026-10-06T13:37:26.285Z.

Quote observation: 2026-10-06T13:32:01.000Z. Amounts in USD. The price header may show a later quote.

Quote price: 1.9189
Unrounded diluted TTM EPS · period ending 2026-06-30: -0.54

FMP input reference: 521b0ab3da901f2a49dafbbedcb3688a082548b97bbb2cd5efdb729e6989e7c5

Forward PE Ratio|PEG Ratio|P/B Ratio|EPS|All Metrics

HURA PE Ratio Metrics

PE RATIO

N/A

HURA Competitors' PE Ratio

HURA

TuHURA Biosciences, Inc.

Current

Market Cap

$122.20M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

IMDX

Insight Molecular Diagnostics Inc.

vs HURA

Market Cap

$120.80M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ENGN

enGene Holdings Inc.

vs HURA

Market Cap

$124.27M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CRBU

Caribou Biosciences, Inc.

vs HURA

Market Cap

$118.42M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BGM

BGM Group Ltd.

vs HURA

Market Cap

$117.87M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

GNLX

Genelux Corporation

vs HURA

Market Cap

$117.48M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

FHTX

Foghorn Therapeutics Inc.

vs HURA

Market Cap

$115.67M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

AARD

Aardvark Therapeutics, Inc. Common Stock

vs HURA

Market Cap

$115.44M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ENTX

Entera Bio Ltd.

vs HURA

Market Cap

$129.39M

PE Ratio

N/A

TTM Avg

2.13

3Y Avg

2.46

5Y Avg

2.46

CBUS

Cibus, Inc.

vs HURA

Market Cap

$129.76M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	PE RATIO	TTM	3Y	5Y
TuHURA Biosciences, Inc. (HURA)	$122.20M	N/A	N/A	N/A	N/A
Insight Molecular Diagnostics Inc. (IMDX)vs ›	$120.80M	N/A	N/A	N/A	N/A
enGene Holdings Inc. (ENGN)vs ›	$124.27M	N/A	N/A	N/A	N/A
Caribou Biosciences, Inc. (CRBU)vs ›	$118.42M	N/A	N/A	N/A	N/A
BGM Group Ltd. (BGM)vs ›	$117.87M	N/A	N/A	N/A	N/A
Genelux Corporation (GNLX)vs ›	$117.48M	N/A	N/A	N/A	N/A
Foghorn Therapeutics Inc. (FHTX)vs ›	$115.67M	N/A	N/A	N/A	N/A
Aardvark Therapeutics, Inc. Common Stock (AARD)vs ›	$115.44M	N/A	N/A	N/A	N/A
Entera Bio Ltd. (ENTX)vs ›	$129.39M	N/A	2.13	2.46	2.46
Cibus, Inc. (CBUS)vs ›	$129.76M	N/A	N/A	N/A	N/A

P/E Comparison

Trailing P/E

N/A

Forward P/E

N/A

Forward P/E Calculation

View All Analyst Estimates

Forward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.

Calculation:

Current Price

$1.92

Forward EPS (Est.)

$-0.55

Forward P/E

N/A

Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.

PE Ratio Formula & Definition

PE Ratio = Share Price / Diluted EPS (TTM)

The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

See the Lowest P/E Ratio Stocks ranking →

PE Ratio: N/A

HURA PE Ratio Metrics

HURA Competitors' PE Ratio

P/E Comparison

Forward P/E Calculation

PE Ratio Formula & Definition

Related Metrics